Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. (Q53407584)

14 May 2018

title

Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. (English)

1 reference

14 May 2018

author name string

L Tessitore

1

1 reference

14 May 2018

A Davit

2

1 reference

14 May 2018

I Sarotto

3

1 reference

14 May 2018

G Caderni

4

1 reference

14 May 2018

language of work or name

English

0 references

publication date

1 August 2000

1 reference

14 May 2018

published in

Carcinogenesis

1 reference

14 May 2018

volume

21

1 reference

14 May 2018

issue

8

1 reference

14 May 2018

page(s)

1619-1622

1 reference

14 May 2018

Expression of a stilbene synthase gene in Nicotiana tabacum results in synthesis of the phytoalexin resveratrol.

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F21.5.619

Wine, alcohol, platelets, and the French paradox for coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F21.5.619

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F21.5.619

Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F21.5.619

Colon cancer: a review of the epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F21.5.619

Fasting/re-feeding before initiation enhances the growth of aberrant crypt foci induced by azoxymethane in rat colon and rectum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F21.5.619

Colon cancer is induced by a single low dose of azoxymethane in fasted-refed rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F21.5.619

Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F21.5.619

Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F21.5.619

Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F21.5.619

Aspirin use and reduced risk of fatal colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F21.5.619

Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F21.5.619

Increased cell proliferation of azoxymethane-induced aberrant crypt foci of rat colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F21.5.619

p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F21.5.619

Resveratrol arrests the cell division cycle at S/G2 phase transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F21.5.619

DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F21.5.619

Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2F21.5.619

21 January 2018

Identifiers

DOI

10.1093/CARCIN/21.5.619

1 reference

14 May 2018

PubMed ID

10910967

1 reference

14 May 2018